Literature DB >> 28739632

Therapeutic potential of mesenchymal stem cells for diabetes.

Alvaro Moreira1, Samuel Kahlenberg2, Peter Hornsby3.   

Abstract

Mesenchymal stem cells (MSCs) are self-renewing multipotent cells that have the capacity to secrete multiple biologic factors that can restore and repair injured tissues. Preclinical and clinical evidence have substantiated the therapeutic benefit of MSCs in various medical conditions. Currently, MSCs are the most commonly used cell-based therapy in clinical trials because of their regenerative effects, ease of isolation and low immunogenicity. Experimental and clinical studies have provided promising results using MSCs to treat diabetes. This review will summarize the role of MSCs on tissue repair, provide emerging strategies to improve MSC function and describe how these processes translate to clinical treatments for diabetes.
© 2017 Society for Endocrinology.

Entities:  

Keywords:  diabetes; endocrine; mesenchymal stem cell; tissue regeneration

Mesh：

Year:  2017        PMID： 28739632      PMCID： PMC5570611          DOI： 10.1530/JME-17-0117

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN： 0952-5041            Impact factor:   5.098


  58 in total

Review 1.  Use of mesenchymal stem cells to treat liver fibrosis: current situation and future prospects.

Authors:  Silvia Berardis; Prenali Dwisthi Sattwika; Mustapha Najimi; Etienne Marc Sokal
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

2.  Osteogenic differentiation of mesenchymal stem cells is regulated by osteocyte and osteoblast cells in a simplified bone niche.

Authors:  E Birmingham; G L Niebur; P E McHugh; G Shaw; F P Barry; L M McNamara
Journal:  Eur Cell Mater       Date:  2012-01-12       Impact factor: 3.942

3.  Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study.

Authors:  Ranhua Jiang; Zhibo Han; Guangsheng Zhuo; Xiaodan Qu; Xue Li; Xin Wang; Yuankang Shao; Shimin Yang; Zhong Chao Han
Journal:  Front Med       Date:  2011-03-17       Impact factor: 4.592

4.  Human Wharton's jelly stem cells have unique transcriptome profiles compared to human embryonic stem cells and other mesenchymal stem cells.

Authors:  Chui-Yee Fong; Li-Ling Chak; Arijit Biswas; Jee-Hian Tan; Kalamegam Gauthaman; Woon-Khiong Chan; Ariff Bongso
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

Review 5.  Chronic inflammation in obesity and the metabolic syndrome.

Authors:  Rosário Monteiro; Isabel Azevedo
Journal:  Mediators Inflamm       Date:  2010-07-14       Impact factor: 4.711

6.  Preserved β-cell function in type 1 diabetes by mesenchymal stromal cells.

Authors:  Per-Ola Carlsson; Erik Schwarcz; Olle Korsgren; Katarina Le Blanc
Journal:  Diabetes       Date:  2014-09-09       Impact factor: 9.461

7.  A comparison of Wharton's jelly and cord blood as a source of mesenchymal stem cells for diabetes cell therapy.

Authors:  Rasha F El-Demerdash; Lamiaa N Hammad; Mohamed M Kamal; Hala O El Mesallamy
Journal:  Regen Med       Date:  2015-11-06       Impact factor: 3.806

Review 8.  Mesenchymal stem cell-based treatments for stroke, neural trauma, and heat stroke.

Authors:  Yogi Chang-Yo Hsuan; Cheng-Hsien Lin; Ching-Ping Chang; Mao-Tsun Lin
Journal:  Brain Behav       Date:  2016-08-03       Impact factor: 2.708

Review 9.  Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine.

Authors:  Matthew B Murphy; Kathryn Moncivais; Arnold I Caplan
Journal:  Exp Mol Med       Date:  2013-11-15       Impact factor: 8.718

10.  Manufacturing Cells for Clinical Use.

Authors:  Mark L Weiss; Mahendra S Rao; Robert Deans; Peter Czermak
Journal:  Stem Cells Int       Date:  2016-06-12       Impact factor: 5.443
View more
  29 in total

Review 1.  Enhancing the Therapeutic Potential of Mesenchymal Stem Cells with the CRISPR-Cas System.

Authors:  Daniel Mendes Filho; Patrícia de Carvalho Ribeiro; Lucas Felipe Oliveira; Ana Luiza Romero Terra Dos Santos; Ricardo Cambraia Parreira; Mauro Cunha Xavier Pinto; Rodrigo Ribeiro Resende
Journal:  Stem Cell Rev Rep       Date:  2019-08       Impact factor: 5.739

Review 2.  Upcycling umbilical cords: bridging regenerative medicine with neonatology.

Authors:  Alvaro Moreira; Yasmeen Alayli; Saloni Balgi; Caitlyn Winter; Samuel Kahlenberg; Shamimunisa Mustafa; Peter Hornsby
Journal:  J Matern Fetal Neonatal Med       Date:  2017-11-27

3.  Effects of mesenchymal stromal cells on motor function and collagen in the skeletal muscles of rats with type I diabetes.

Authors:  Genoveva L F Luna; Thiago L Russo; Maria A Sabadine; Yisel C Estrada-Bonilla; Ana L M Andrade; Patricia Brassolatti; Fernanda F Anibal; Ângela M O Leal
Journal:  Int J Exp Pathol       Date:  2020-02-06       Impact factor: 1.925

4.  Mesenchymal stem cell transplantation in newly diagnosed type-1 diabetes patients: a phase I/II randomized placebo-controlled clinical trial.

Authors:  Mahmoud Izadi; Anavasadat Sadr Hashemi Nejad; Maedeh Moazenchi; Safdar Masoumi; Ali Rabbani; Farzad Kompani; Amir Abbas Hedayati Asl; Fatemeh Abbasi Kakroodi; Neda Jaroughi; Mohammad Ali Mohseni Meybodi; Aria Setoodeh; Farzaneh Abbasi; Seyedeh Esmat Hosseini; Fatemeh Moeini Nia; Reza Salman Yazdi; Roghayeh Navabi; Ensiyeh Hajizadeh-Saffar; Hossein Baharvand
Journal:  Stem Cell Res Ther       Date:  2022-06-20       Impact factor: 8.079

5.  Human Wharton's Jelly Mesenchymal Stem Cells Secretome Inhibits Human SARS-CoV-2 and Avian Infectious Bronchitis Coronaviruses.

Authors:  Mohamed A A Hussein; Hosni A M Hussein; Ali A Thabet; Karim M Selim; Mervat A Dawood; Ahmed M El-Adly; Ahmed A Wardany; Ali Sobhy; Sameh Magdeldin; Aya Osama; Ali M Anwar; Mohammed Abdel-Wahab; Hussam Askar; Elsayed K Bakhiet; Serageldeen Sultan; Amgad A Ezzat; Usama Abdel Raouf; Magdy M Afifi
Journal:  Cells       Date:  2022-04-21       Impact factor: 7.666

Review 6.  Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases.

Authors:  Jinsha Liu; Joey Paolo Ting; Shams Al-Azzam; Yun Ding; Sepideh Afshar
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

7.  MiR-34a suppression targets Nampt to ameliorate bone marrow mesenchymal stem cell senescence by regulating NAD+-Sirt1 pathway.

Authors:  Chenchen Pi; Cao Ma; Huan Wang; Hui Sun; Xiao Yu; Xingyu Gao; Yue Yang; Yanan Sun; Haiying Zhang; Yingai Shi; Yan Li; Yulin Li; Xu He
Journal:  Stem Cell Res Ther       Date:  2021-05-06       Impact factor: 6.832

Review 8.  Human umbilical cord mesenchymal stem cells in type 2 diabetes mellitus: the emerging therapeutic approach.

Authors:  Andreia Gomes; Pedro Coelho; Raquel Soares; Raquel Costa
Journal:  Cell Tissue Res       Date:  2021-05-29       Impact factor: 5.249

9.  Analysis of the miRNA and mRNA involved in osteogenesis of adipose-derived mesenchymal stem cells.

Authors:  Bo Jia; Zhaoqiang Zhang; Xiaoling Qiu; Hongxing Chu; Xiang Sun; Xianghuai Zheng; Jianjiang Zhao; Qin Li
Journal:  Exp Ther Med       Date:  2018-06-13       Impact factor: 2.447

Review 10.  CCN5/WISP2 and metabolic diseases.

Authors:  John R Grünberg; Johannes Elvin; Alexandra Paul; Shahram Hedjazifar; Ann Hammarstedt; Ulf Smith
Journal:  J Cell Commun Signal       Date:  2017-12-15       Impact factor: 5.782
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.